Category: Disappointing
-
NICE Systems falls sharply on disappointing 2025 guidance
•
Israeli technology company Nice Systems Ltd. (Nasdak: Cute – Good;; level:Cute – GoodHe overcame analysts in the financial results in the fourth quarter published today. But the market was disappointed by the company’s 2025 directives, and the share price decreased by 16 % on the Nasdaq Stock Exchange, which gave…
-
Mobileye falls on disappointing 2025 guidance
•
Israeli advanced leadership assistance company (Adas) Mobileye Global Inc (NASDAQ: MBLE) ended a difficult year by overcoming balconies in its financial results in the fourth quarter, but guidance for investors disappointed 2025 and witnessed a sharp decrease in the price of his share in the pre -market trading in Wall…
-
Teva falls sharply on disappointing 2025 guidance
•
Teva Pharmaceutical Industries Ltd. (NYSE: Tifa;; level: Tiva) The reports season of Israeli companies were opened by publishing the financial results in the fourth and full year 2024. In the fourth quarter, the company reported revenues of $ 4.2 billion and NON-GAAP per share of $ 0.71, higher than analysts’…
-
CrowdStrike Falls After Disappointing Earnings Outlook
•
(Bloomberg) — CrowdStrike Holdings Inc. Earnings forecasts were weaker than expected, disappointing investors who were watching for signs that the cybersecurity company had recovered from a faulty update that crashed computers around the world. Most read from Bloomberg Adjusted earnings will range from 84 cents to 86 cents per share…
-
CrowdStrike Falls After Disappointing Earnings Outlook
•
(Bloomberg) — CrowdStrike Holdings Inc. Earnings forecasts were weaker than expected, disappointing investors who were watching for signs that the cybersecurity company had recovered from a faulty update that crashed computers around the world. Most read from Bloomberg Adjusted earnings will range from 84 cents to 86 cents per share…
-
Ulta Beauty reports disappointing earnings after Warren Buffett’s Berkshire Hathaway takes stake
•
Ulta Beauty’s (ULTA) glow-up period may have come to an end. The cosmetics retailer reported second-quarter results Thursday after the market closed that missed expectations across the board. Revenue came in at $2.55 billion, compared with an expected $2.62 billion. Earnings per share of $5.30 also fell short of the…
-
Outset Medical reports disappointing earnings in second-quarter By Investing.com
•
Outset Medical (NASDAQ: OM), a medical technology company, reported second-quarter earnings for 2024 that missed market expectations, primarily due to a slower ramp-up of its TabloCart product and an extended sales cycle. Despite these challenges, the company highlighted several positive aspects of its performance, such as strong treatment sales and…